Clinical Trials
Sorrento begin patient enrollment in phase 2 study of COVI-MSC to treat Covid-19 associated ARD in ICU patients
Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC™) for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS) in Brazil....
Drug Research
Dr Reddy’s Lab gains on deal with Citius Pharma for anti-cancer agent E7777
Dr.Reddy's Laboratories rose 0.71% to Rs 4934 after the company signed a deal with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox).
In an exchange filing made on Saturday (4 September 2021), the drug maker...
News
Integrated Solutions to Facilitate the Manufacturing of Gene Therapies
The efficacy and safety of approved viral vector-based COVID-19 vaccines will not only stimulate further development in this area but also spotlights the importance of robust and scalable manufacturing solutions that can fully meet the demands for the clinical...
News
Overcoming Transfection Scaling Challenges for Viral Vector Manufacturing
Gene therapies delivered using viral vectors offer exciting potential to welcome a new type of treatment for various disease indications. However, one of the most complex steps to develop and scale for viral vector transient production based on adenovirus...
News
Aware Gleneagles Global Hospital commemorates World Physiotherapy Day
Physiotherapy or Physical Therapy helps people recover from an injury, relieve pain, prevent future injury, or deal with a chronic condition; and now it has been noticed that it helps people overcome the after-effects of Covid-19 infections or related...
News
Ardena acquires Idifarma from Suanfarma and Sodena, adding spray drying technology and high potency capabilities
Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), has announced that it has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs.
The acquisition from Suanfarma delivers expansion across Southern Europe and...
News
Quanticate appoints new Head of Machine Learning and Digital Transformation
Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Piotr Karasiewicz as the company's new Head of Machine Learning and Digital Transformation to lead process improvements and ensure efficient and high-quality data analysis.
Reporting to Quanticate's Chairman and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.